drugset / Trial / NCT01159015

Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers

NCT01159015 ↗

Phase 3 Completed 534 enrolled Bausch & Lomb Incorporated
RandomizedParallel-groupTriple-blindScreening

Summary

This study is being conducted to evaluate the safety of KetoNaph ophthalmic solution in healthy adult subjects and in pediatric subjects with a history or family history of ocular allergy.

Timeline

Start
2010-07
Primary completion
2010-09
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject KetoNaph Unknown — Other

Indications